Top 10 Best-Selling Cancer Drugs, Q1–Q3 2017
15% Year-Over-Year Growth, with Sales Set to More than Double by 2022
Biomaterials Could Extend the Success of Immunotherapies
A New Review Paper Encourages Clinicians to Pull Ideas from the Desks of Engineers
Bioelectricity, New Peer Reviewed Journal Announced
An Outstanding and Influential Foundation for a Dynamic, Emerging Field
Vaccine Industry Retools Itself for Speed
Vaccine Manufacturing Moves toward Mass Customization
For full access to this article login to GEN Select now.
Unlocking the Potential of CRISPR-Based Gene Editing
The Future of the Gene-Editing Method of Choice
- The CRISPR/Cas9 system is a fast-emerging technology that has transformed our ability to precisely target genomic sites. Compared to other gene-editing technologies (e.g., ZFNs and TALENs), it is simpler to re-engineer, relatively inexpensive, easier to use, and has broad versatility, high efficiency, and can target multiple sites. 1 ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.